[Therapeutic results with Bactrim in typhoid fever, paratyphoid fever, and other salmonelloses].
D000328:Adult; D000667:Ampicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002701:Chloramphenicol / Q000627:therapeutic use; D004338:Drug Combinations; D005243:Feces / Q000382:microbiology; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010284:Paratyphoid Fever / Q000188:drug therapy*; D010403:Penicillin Resistance; D011743:Pyrimidines / Q000627:therapeutic use*; D012475:Salmonella / Q000302:isolation & purification; D012480:Salmonella Infections / Q000188:drug therapy*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use; D014435:Typhoid Fever / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D002701:Chloramphenicol; D000667:Ampicillin; D014295:Trimethoprim; D013420:Sulfamethoxazole
Behandlungsresultate mit Bactrim bei Typhus, Paratyphus und anderen Salmonellosen.